The Postdoctoral Scholar in the Eil lab will be a critical member of our burgeoning group studying tumor immunology and T cell signaling in the tumor microenvironment. Dr. Eil is a surgeon-scientist with a track record of discovery and innovation in this rapidly evolving and exciting field (Eil R, et al. Nature 2016, PMID 27626381; Eil R, et al Science 2019, PMID 30923193). Dr. Eil started his laboratory in August 2020 and has an actively funded research program. The Postdoctoral Scholar will perform research consistent with the goals of a Principal Investigator or manage a service core. These functions require specialized or technological expertise, including complex principles and practices. This position would be an ideal opportunity to establish a long-term relationship guiding role in the direction of a lab in early phases. The Eil lab will grow significantly over the next several years. Benefits of this position include opportunity acquisition of skills relevant to T cell immunotherapy, access to clinical samples, potential collaboration with external biotechnology (if desired), ownership of independent scientific projects, and input on laboratory direction that would not otherwise be possible in larger established groups. Salary for this position aligns with the NIH Scale .
Apply here online. Please be sure to upload a cover letter and Resume or CV. Oregon Health & Science University values a diverse and culturally competent workforce. We are proud of our commitment to being an equal opportunity, affirmative action organization that does not discriminate against applicants on the basis of any protected class status, including disability status and protected veteran status. Individuals with diverse backgrounds and those who promote diversity and a culture of inclusion are encouraged to apply. To request reasonable accommodation contact the Affirmative Action and Equal Opportunity Department at 503-494-5148 or aaeo@ohsu.edu. Options Sorry the Share function is not working properly at this moment. Please refresh the page and try again later. Share on your newsfeed Loading... Application FAQs Software Powered by iCIMS
|
|